Chemoinformaics analysis of 4-o-caffeoylquinic-acid
| Molecular Weight | 232.323 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 3 |
| Exact Molecular Weight | 232.146 | nRing | 2 |
| Solubility: LogS | -5.545 | nHRing | 0 |
| Solubility: LogP | 6.158 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 1 | BPOL | 20.9321 |
| QED | 0.236 |
| Synth | 2.522 |
| Natural Product Likeliness | 1.455 |
| NR-PPAR-gamma | 0.786 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.014 |
| HIA | 0.006 |
| CACO-2 | -4.607 |
| MDCK | 0.0000134 |
| BBB | 0.969 |
| PPB | 0.94497 |
| VDSS | 3.01 |
| FU | 0.0307098 |
| CYP1A2-inh | 0.812 |
| CYP1A2-sub | 0.179 |
| CYP2c19-inh | 0.482 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.42 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.31 |
| CYP2d6-sub | 0.258 |
| CYP3a4-inh | 0.537 |
| CYP3a4-sub | 0.049 |
| CL | 6.226 |
| T12 | 0.219 |
| hERG | 0.064 |
| Ames | 0.361 |
| ROA | 0.006 |
| SkinSen | 0.986 |
| Carcinogencity | 0.331 |
| EI | 0.976 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.624 |
| Antiviral | Yes |
| Prediction | 0.733312 |